Note Regarding Forward-looking Statements



This report, including "Part I - Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations" and "Part II - Item 1A. Risk
Factors" contains certain forward-looking statements that involve risks and
uncertainties, including statements regarding our strategy, financial
performance and revenue sources. We use words such as "anticipate," "believe,"
"plan," "expect," "future," "continue," "intend" and similar expressions to
identify forward-looking statements. Our actual results could differ materially
from the results anticipated in these forward-looking statements as a result of
certain factors including those set forth under "Risk Factors," beginning at
page 38 and elsewhere in this Form 10-Q. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or
achievements. You should not place undue reliance on these forward-looking
statements. We disclaim any obligation to update information contained in any
forward-looking statement. These forward-looking statements include, without
limitation, statements regarding the following:
•Our expectation that certain supply chain constraints will continue through
calendar 2022 and possibly beyond;
•That if the impact of COVID-19 worsens, the pandemic could adversely impact our
business in future periods;
•That local governments could require us or our suppliers to temporarily reduce
production further, cease operations, or implement mandatory vaccine
requirements, and we could experience constraints in fulfilling customer orders;
•The impact that local restrictions could have on our manufacturing operations,
or the manufacturing operations of our subcontractors, in the future;
•That we hope to see more of our team members return to our offices in the
coming months, contingent on local conditions;
•Our belief that our actions to combat the spread of COVID-19 will help preserve
the health of our team members, customers, suppliers, visitors to our
facilities, people with whom we conduct business and our communities, and allow
us to safely continue operations;
•Our inability to predict how the COVID-19 pandemic, and actions taken by others
in response to it, will affect our business;
•The effects that uncertain global economic conditions and fluctuations in the
global credit and equity markets may have on our financial condition and results
of operations;
•The effects and amount of competitive pricing pressure on our product lines and
modest pricing declines in certain of our more mature proprietary product lines;
•Our ability to moderate future average selling price declines;
•The effect of product mix, capacity utilization, yields, fixed cost absorption,
competition and economic conditions on gross margin;
•The amount of, and changes in, demand for our products and those of our
customers;
•The impact of national security protections, trade restrictions and changes in
tariffs, including those impacting China;
•Our expectation that in the future we will acquire additional businesses that
we believe will complement our existing businesses;
•Our expectation that in the future we will enter into joint development
agreements or other strategic relationships with other companies;
•The level of orders that will be received and shipped within a quarter,
including the impact of our product lead times;
•Our expectation that our days of inventory at December 31, 2021 will be 112 to
118 days;
•Our belief that customers recognize our products and brand name and use
distributors as an effective supply channel;
•The accuracy of our estimates of the useful life and values of our property,
assets and other liabilities;
•Our ability to increase the proprietary portion of our analog product line and
the effect of such an increase;
•The impact of any supply disruption we may experience;
•Our ability to effectively utilize our facilities at appropriate capacity
levels and anticipated costs;
•That we adjust capacity utilization to respond to actual and anticipated
business and industry-related conditions;
•That manufacturing costs will be reduced by transition to advanced process
technologies;
•Our ability to maintain manufacturing yields;
•Continuing our investments in new and enhanced products;
•The cost effectiveness of using our own assembly and test operations;
•Our expectation that foundry capacity will continue to be tight due to strong
demand for wafers across the industry;
                                       24
--------------------------------------------------------------------------------
  Table of Contents
•Our expectation that we will continue to operate our manufacturing facilities
at or above normal capacity if the current supply constraints relative to demand
continue;
•Our anticipated level of capital expenditures;
•Continuation and amount of quarterly cash dividends;
•The sufficiency of our existing sources of liquidity to finance anticipated
capital expenditures and otherwise meet our anticipated cash requirements, and
the effects that our contractual obligations are expected to have on them;
•The impact of seasonality on our business;
•Our belief that our IT system compromise has not had a material adverse effect
on our business or resulted in any material damage to us;
•Our expectation that we will continue to be the target of cyber-attacks,
computer viruses, unauthorized access and other attempts to breach or otherwise
compromise the security of our IT systems and data;
•The accuracy of our estimates used in valuing employee equity awards;
•That the resolution of legal actions will not have a material effect on our
business, and the accuracy of our assessment of the probability of loss and
range of potential loss;
•The accuracy of our estimated tax rate;
•Our belief that the expiration of any tax holidays will not have a material
impact on our effective tax rate;
•The impact of the geographical dispersion of our earnings and losses on our
effective tax rate;
•Our belief that the estimates used in preparing our condensed consolidated
financial statements are reasonable;
•Our actions to vigorously and aggressively defend and protect our intellectual
property on a worldwide basis;
•Our ability to obtain patents and intellectual property licenses and minimize
the effects of litigation;
•The level of risk we are exposed to for product liability claims or
indemnification claims;
•The effect of fluctuations in market interest rates on our income and/or cash
flows;
•The effect of fluctuations in currency rates;
•That we could increase our borrowings or seek additional equity or debt
financing to maintain or expand our facilities, or to fund cash dividends, share
repurchases, acquisitions or other corporate activities, and that the timing and
amount of such financing requirements will depend on a number of factors;
•Our intention to satisfy the lesser of the principal amount or the conversion
value of our Convertible Debt in cash;
•Our intention to invest substantially all of our foreign subsidiary earnings,
as well as our capital in our foreign subsidiaries, indefinitely outside of the
U.S. in those jurisdictions in which we would incur significant, additional
costs upon repatriation of such amounts;
•Our expectation that our reliance on third party contractors may increase over
time as our business grows;
•Our ability to collect accounts receivable; and
•The impact of the legislative and policy changes implemented or which may be
implemented by the current administration, on our business and the trading price
of our stock.

Our actual results could differ materially from the results anticipated in these
forward-looking statements as a result of certain factors including those set
forth in "Item 1A. Risk Factors," and elsewhere in this Form 10-Q. Although we
believe that the expectations reflected in our forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity, performance
or achievements. You should not place undue reliance on these forward-looking
statements. We disclaim any obligation to update the information contained in
any forward-looking statement.

                                       25
--------------------------------------------------------------------------------
  Table of Contents
Introduction

The following discussion should be read in conjunction with the condensed consolidated financial statements and the related notes that appear elsewhere in this document.



We begin our Management's Discussion and Analysis of Financial Condition and
Results of Operations with a summary of COVID-19 developments followed by a
summary of our overall business strategy to give the reader an overview of the
goals and overall direction of our business. This is followed by a discussion of
the Critical Accounting Policies and Estimates that we believe are important to
understanding the assumptions and judgments incorporated in our reported
financial results. We then discuss our Results of Operations for the three and
six months ended September 30, 2021 compared to the three and six months ended
September 30, 2020, followed by an analysis of changes in our balance sheet and
cash flows, and discuss our financial commitments in the section titled
"Liquidity and Capital Resources."

COVID-19 Developments



In the first half of fiscal 2021, the COVID-19 pandemic resulted in a global
disruption in economic activity by adversely affecting production, creating
supply chain and market disruption, and adversely impacting businesses and
individuals. In the second half of fiscal 2021, business conditions were
unexpectedly strong as businesses and individuals adapted to the effects of the
pandemic. Business conditions have continued to be exceptionally strong through
the first half of fiscal 2022. At this time, our global manufacturing sites and
our logistics channels are fully operational; however, local restrictions have
adversely impacted certain subcontractors' manufacturing operations and could
adversely impact either our subcontractors or our own manufacturing operations
in the future. If the impact of COVID-19 worsens, the pandemic could adversely
impact our business in future periods.

In response to the early indications of the COVID-19 pandemic, we took proactive
measures to safeguard the health of our employees, contractors, customers,
suppliers, visitors to our facilities, other business partners, and our
communities. We strategically implemented plans intended to ensure business
continuity in the event severe outbreaks or government requirements were to
impact our operations. We monitor governmental policies and CDC recommendations
and take appropriate actions which are designed to prevent and control the
spread of COVID-19.

We continuously assess our efforts to combat the COVID-19 pandemic which have
included the following:
•We previously suspended attendance at conferences and other gatherings but
recently began to allow limited business travel. While we continue to evolve our
work model in response to the ongoing effects of the pandemic, we have some team
members that have fully transitioned into working at the office, and we hope to
see more of our team members return to our offices in the coming months,
contingent on local conditions. All on-site team members are requested to stay
home if they do not feel well, stay home if they have been exposed to someone
with COVID-19 or its symptoms, maintain a safe distance from others, wash their
hands frequently, and wear a mask in common areas at on-site locations. We clean
high touch surfaces at least daily.
•In partnership with our suppliers, we have evaluated our supply chain to
identify gaps or weak points. In order to ensure continuity, in some cases, we
have qualified alternative suppliers and increased our inventory of raw
materials.
•We have added and continue to add assembly and test capacity to increase our
manufacturing capability.
•We initially implemented measures to help prepare for economic uncertainty,
such as employee salary cuts, limiting hiring, reducing business travel costs,
reducing discretionary spending, and limiting capital expenditures. However, in
December 2020, we restored previous reductions in compensation, resumed hiring,
and increased spending for capital expenditures to help meet business demands.
•We are working with government authorities in the areas where we have a
significant footprint. We continue to update ourselves on government
requirements, relevant regulations, industry standards, and best practices to
help safeguard our team members across the globe.

We believe these actions are important and will help preserve the health of our
team members, customers, suppliers, visitors to our facilities, people with whom
we conduct business and our communities, and allow us to safely continue
operations. However, we cannot predict how these actions, or the actions taken
by government entities, suppliers, or customers in response to the COVID-19
pandemic will impact our business, revenues, or results of operations.

Strategy

We develop, manufacture and sell smart, connected and secure embedded control solutions used by our customers for a wide variety of applications. Our strategic focus includes general purpose and specialized 8-bit, 16-bit, and 32-bit


                                       26
--------------------------------------------------------------------------------
  Table of Contents
microcontrollers, microprocessors, analog, FPGA, and memory products. With over
30 years of technology leadership, our broad product portfolio is a Total System
Solution (TSS) for our customers that provides a large portion of the silicon
requirements in their applications. TSS is a combination of hardware, software
and services which help our customers increase their revenue, reduce their costs
and manage their risks compared to other solutions. Our synergistic product
portfolio empowers disruptive growth trends, including 5G, artificial
intelligence and machine learning, Internet of Things (IoT), advanced driver
assist systems (ADAS) and autonomous driving, and electric vehicles, in key end
markets such as automotive, aerospace and defense, communications, consumer,
data centers and computing, and industrial.

Our manufacturing operations include wafer fabrication, wafer probe, assembly
and test. The ownership of a substantial portion of our manufacturing resources
is an important component of our business strategy, enabling us to maintain a
high level of manufacturing control, resulting in us being one of the lowest
cost producers in the embedded control industry. By owning wafer fabrication
facilities and our assembly and test operations, and by employing statistical
techniques (statistical process control, designed experiments and wafer level
monitoring), we have been able to achieve and maintain high production
yields. Direct control over manufacturing resources allows us to shorten our
design and production cycles. This control also allows us to capture a portion
of the wafer manufacturing and assembly and testing profit margin. We do
outsource a significant portion of our manufacturing requirements to third
parties and the amount of our outsourced manufacturing has increased in recent
years due to our acquisitions of Microsemi and other companies that outsourced
all or substantial portions of their manufacturing.

We employ proprietary design and manufacturing processes in developing our
embedded control products. We believe our processes afford us both
cost-effective designs in existing and derivative products and greater
functionality in new product designs. While many of our competitors develop and
optimize separate processes for their logic and memory product lines, we use a
common process technology for both microcontroller and non-volatile memory
products. This allows us to more fully leverage our process research and
development costs and to deliver new products to market more rapidly. Our
engineers utilize advanced computer-aided design tools and software to perform
circuit design, simulation and layout, and our in-house photomask and wafer
fabrication facilities enable us to rapidly verify design techniques by
processing test wafers quickly and efficiently.

We are committed to continuing our investment in new and enhanced products,
including development systems, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. Our current research and development
activities focus on the design of new microcontrollers, digital signal
controllers, memory, analog and mixed-signal products, FPGAs, timing systems,
Flash-IP, development systems, software and application-specific software
libraries. We are also developing new design and process technologies to achieve
further cost reductions and performance improvements in our products.

We market and sell our products worldwide primarily through a network of direct
sales personnel and distributors. Our direct sales force focuses on a wide
variety of strategic accounts in three geographical markets: the Americas,
Europe and Asia. We currently maintain sales and technical support centers in
major metropolitan areas in all three geographic markets. We believe that a
strong technical service presence is essential to the continued development of
the embedded control market. Many of our CEMs, ESEs, and sales management have
technical degrees or backgrounds and have been previously employed in high
technology environments. We believe that the technical and business knowledge of
our sales force is a key competitive advantage in the sale of our products. The
primary mission of our ESE team is to provide technical assistance to customers
and to conduct periodic training sessions for the balance of our sales
team. ESEs also frequently conduct technical seminars and workshops in major
cities around the world or through online webcasts. Our licensing division has
dedicated sales, technology, design, product, test and reliability personnel
that support the requirements of our licensees.

In the fourth quarter of fiscal 2021, we launched our Preferred Supply Program,
which provides our customers with prioritized capacity beginning 6 months after
their order of 12 months of continuous, non-cancellable and non-reschedulable
backlog. Demand outpaced capacity improvements that we implemented in the first
half of fiscal 2022 resulting in lead times continuing to extend out. We
experienced constraints in our internal and external factories and their related
manufacturing supply chains. We worked closely with our wafer fabrication,
assembly and test subcontractors to secure additional capacity wherever
possible. We expect that certain wafer fabrication, assembly and test
constraints will persist through calendar 2022 and possibly beyond.

See "Our operating results are impacted by seasonality and wide fluctuations of
supply and demand in the industry," on page 44 for discussion of the impact of
seasonality on our business.

                                       27
--------------------------------------------------------------------------------
  Table of Contents
Critical Accounting Policies and Estimates

Except for the changes discussed in "Recently Adopted Accounting Pronouncements"
in Note 2 to our condensed consolidated financial statements in this Form 10-Q,
there were no changes to our critical accounting policies and estimates during
the first six months of the fiscal year ending March 31, 2022 compared to our
"Critical Accounting Policies and Estimates" as previously described in Part II,
Item 7 of our Annual Report on Form 10-K for the fiscal year ended March 31,
2021.

Results of Operations

The following table sets forth certain operational data as a percentage of net sales for the periods covered by this report:


                                            Three Months Ended September 30,                Six Months Ended September 30,
                                                                                            2021                      2020                     2021                     2020
Net sales                                                                                       100.0  %                 100.0  %                 100.0  %                 100.0  %
Cost of sales                                                                                    35.2                     38.3                     35.5                     38.7
Gross profit                                                                                     64.8                     61.7                     64.5                     61.3

Research and development                                                                         14.9                     15.3                     15.1                     15.2
Selling, general and
administrative                                                                                   10.9                     11.1                     11.0                     11.1
Amortization of acquired
intangible assets                                                                                13.2                     17.7                     13.4                     17.8
Special charges and other, net                                                                    0.6                      0.3                      0.6                      0.2
Operating income                                                                                 25.2  %                  17.3  %                  24.4  %                  17.0  %



Net Sales

We operate in two industry segments and engage primarily in the design,
development, manufacture and sale of semiconductor products as well as the
licensing of our SuperFlash and other technologies. We sell our products to
distributors and OEMs in a broad range of markets, perform ongoing credit
evaluations of our customers and generally require no collateral. In certain
circumstances, a customer's financial condition may require collateral, and, in
such cases, the collateral would be typically provided in the form of letters of
credit.

The following table summarizes our net sales for the periods covered by this report (dollars in millions):


                                                               Three Months Ended September 30,                                Six Months Ended September 30,
                                                        2021                2020               Change                   2021                  2020               Change
Net sales                                           $  1,649.8          $

1,309.5                  26.0  %       $       3,219.2          $ 2,619.2                  22.9  %



The increases in net sales in the three and six months ended September 30, 2021
compared to the three and six months ended September 30, 2020 were primarily due
to strong business conditions that began in the second half of fiscal 2021 as
businesses and individuals adapted to the effects of the COIVD-19 pandemic.
Business conditions have continued to be exceptionally strong in the three and
six months ended September 30, 2021. Additionally, semiconductor industry
conditions have resulted in increased costs throughout our supply chain, which
we have been passing on to our customers in the form of price increases. These
price increases also contributed to the increases in net sales during the three
and six months ended September 30, 2021 compared to the three and six months
ended September 30, 2020.

The net sales value of inventory at our distributor customers increased $13.5
million during the three months ended September 30, 2021 compared to an increase
of $22.0 million during the three months ended September 30, 2020. Excluding the
impact of changes in distributor inventory levels on net sales, net sales
increased by 27.1% in the three months ended September 30, 2021 compared to the
three months ended September 30, 2020. Demand for our products was positively
impacted by strength in our microcontroller and analog product lines. Due to the
size, complexity and diversity of our customer base, we are not able to quantify
any material factor contributing to the change other than net demand
fluctuations in the end markets that we serve.

The net sales value of inventory at our distributor customers decreased $23.8
million during the six months ended September 30, 2021 compared to an increase
of $38.5 million during the six months ended September 30, 2020. Excluding the
impact of changes in distributor inventory levels on net sales, net sales
increased by 25.7% in the six months ended September 30, 2021 compared to the
six months ended September 30, 2020. Demand for our products was positively
impacted by strength
                                       28
--------------------------------------------------------------------------------
  Table of Contents
in our microcontroller and analog product lines. Due to the size, complexity and
diversity of our customer base, we are not able to quantify any material factor
contributing to the change other than net demand fluctuations in the end markets
that we serve.

Other factors that we believe contributed to changes in our reported net sales
for the three and six months ended September 30, 2021 compared to the three and
six months ended September 30, 2020 and which are drivers of long-term trends in
our net sales but which factors we are not able to quantify include:
•semiconductor industry conditions;
•our various new product offerings that have increased our served available
market;
•customers' increasing needs for the flexibility offered by our programmable
solutions; and
•increasing semiconductor content in our customers' products through our Total
Systems Solutions.

We sell a large number of products to a large and diverse customer base and
there was not any single product or customer that accounted for a material
portion of the change in our net sales in the three and six months ended
September 30, 2021 or September 30, 2020. The overall average selling price of
our products is affected by pricing declines over the life of individual
products; however, variations in our product and geographic mix of sales can
cause wider fluctuations in our overall average selling price in any given
period.

Net sales by product line for the periods covered by this report were as follows (dollars in millions):


                                      Three Months Ended September 30,                           Six Months Ended September 30,

                                                                                              2021                 %                 2020                 %                 2021                 %                 2020                 %
Microcontrollers                                                                          $   894.0                54.1          $   703.1                53.7          $ 1,796.5                55.8          $ 1,419.5                54.2
Analog                                                                                        490.9                29.8              361.7                27.6              923.0                28.7              731.9                27.9
Other                                                                                         264.9                16.1              244.7                18.7              499.7                15.5              467.8                17.9
Total net sales                                                                           $ 1,649.8               100.0          $ 1,309.5               100.0          $ 3,219.2               100.0          $ 2,619.2               100.0



Microcontrollers

Our microcontroller product line represents the largest component of our total
net sales. Microcontrollers and associated application development systems
accounted for approximately 54.1% and 55.8% of our net sales for the three and
six months ended September 30, 2021, respectively, compared to approximately
53.7% and 54.2% of our net sales for the three and six months ended September
30, 2020, respectively.

Net sales of our microcontroller products increased 27.2% and 26.6% in the three
and six months ended September 30, 2021, respectively, compared to the three and
six months ended September 30, 2020. These sales increases were due primarily to
strength in demand for our microcontroller products in end markets that we
serve.

Historically, average selling prices in the semiconductor industry decrease over
the life of any particular product. The overall average selling prices of our
microcontroller products have remained relatively constant over time due to the
proprietary nature of these products. We have in the past been able to, and
expect in the future to be able to, moderate average selling price declines in
our microcontroller product lines by introducing new products with more features
and higher prices. We may be unable to maintain average selling prices for our
microcontroller products as a result of increased pricing pressure in the
future, which would adversely affect our operating results. The average selling
price of our microcontroller products is affected by these trends; however,
variations in our product and geographic mix of sales can cause wider
fluctuations in the average selling price of our microcontroller products in any
given period.

Analog

Our analog product line includes analog, interface, mixed signal and timing
products. Our analog product line accounted for approximately 29.8% and 28.7% of
our net sales for the three and six months ended September 30, 2021,
respectively, compared to approximately 27.6% and 27.9% of our net sales for the
three and six months ended September 30, 2020, respectively.

Net sales from our analog product line increased 35.7% and 26.1% in the three
and six months ended September 30, 2021, respectively, compared to the three and
six months ended September 30, 2020, primarily due to strength in demand for our
analog products in end markets that we serve.

We consider a majority of the products in our analog product line to be proprietary in nature, where prices are relatively stable, similar to the pricing stability experienced in our microcontroller products. The non-proprietary portion of our analog


                                       29
--------------------------------------------------------------------------------
  Table of Contents
product line will experience price fluctuations, driven primarily by the current
supply and demand for those products. We may be unable to maintain the average
selling prices of our analog product line as a result of increased pricing
pressure in the future, which would adversely affect our operating results.

Other



Our other product line includes FPGA products, royalties associated with
licenses for the use of our SuperFlash and other technologies, sales of our
intellectual property, fees for engineering services, memory products, timing
systems, manufacturing services (wafer foundry and assembly and test
subcontracting), legacy application specific integrated circuits, and certain
products for aerospace applications. Revenue from these services and products
accounted for approximately 16.1% and 15.5% of our net sales for the three and
six months ended September 30, 2021, respectively, compared to approximately
18.7% and 17.9% of our net sales for the three and six months ended September
30, 2020, respectively.

Net sales related to these services and products increased 8.3% and 6.8% in the
three and six months ended September 30, 2021, respectively, compared to the
three and six months ended September 30, 2020. These sales increases were
primarily due to strength in demand for our products in end markets that we
serve. Net sales of our other product line can fluctuate over time based on
general economic and semiconductor industry conditions as well as changes in
demand for our FPGA products, licenses, engineering services, memory products,
and manufacturing services (wafer foundry and assembly and test subcontracting).

Distribution



Distributors accounted for approximately 50% of our net sales in each of the
three and six months ended September 30, 2021, compared to approximately 51% of
our net sales in each of the three and six months ended September 30, 2020. No
distributor or end customer accounted for more than 10% of our net sales in the
three and six months ended September 30, 2021 or September 30, 2020. Our
distributors focus primarily on servicing the product requirements of a broad
base of diverse customers. We believe that distributors provide an effective
means of reaching this broad and diverse customer base. We believe that
customers recognize Microchip for its products and brand name and use
distributors as an effective supply channel.

Generally, we do not have long-term agreements with our distributors and we, or
our distributors, may terminate our relationships with each other with little or
no advance notice, with the exception of orders placed under our Preferred
Supply Program. The loss of, or the disruption in the operations of, one or more
of our distributors could reduce our future net sales in a given quarter and
could result in an increase in inventory returns.

At September 30, 2021, our distributors maintained 19 days of inventory of our
products compared to 22 days at March 31, 2021. Over the past ten fiscal years,
the days of inventory maintained by our distributors have fluctuated between
approximately 19 days and 47 days. Inventory holding patterns at our
distributors may have a material impact on our net sales. Our distributor
inventory days are at historic lows due to the imbalance between the supply of
and the demand for our products in the current supply-constrained environment.

Sales by Geography

Sales by geography for the periods covered by this report were as follows (dollars in millions):


                                      Three Months Ended September 30,                           Six Months Ended September 30,
                                                                                              2021                %                 2020                %                 2021                %                 2020                %
Americas                                                                                  $   419.8               25.4          $   345.4               26.4          $   792.9               24.6          $   688.4               26.3
Europe                                                                                        324.6               19.7              237.6               18.1              634.3               19.7              482.9               18.4
Asia                                                                                          905.4               54.9              726.5               55.5            1,792.0               55.7            1,447.9               55.3
Total net sales                                                                           $ 1,649.8              100.0          $ 1,309.5              100.0          $ 3,219.2              100.0          $ 2,619.2              100.0



Americas sales include sales to customers in the U.S., Canada, Central America
and South America. Sales to foreign customers accounted for approximately 77%
and 78% of our total net sales in the three and six months ended September 30,
2021, respectively, compared to approximately 76% of our total net sales in each
of the three and six months ended September 30, 2020. Substantially all of our
foreign sales are U.S. dollar denominated. Sales to customers in Europe as a
percentage of total net sales increased in the three and six months ended
September 30, 2021 compared to the three and six months ended September 30, 2020
primarily due to strength in demand in our microcontroller and analog product
lines. Sales to customers in the Americas increased in the three and six months
ended September 30, 2021 compared to the three and six months ended
                                       30
--------------------------------------------------------------------------------
  Table of Contents
September 30, 2020, however, they decreased as a percentage of total net sales
due to strength in demand for our products in the Europe and Asia markets. Our
sales force in the Americas and Europe supports a significant portion of the
design activity for products which are ultimately shipped to Asia.

Gross Profit



Our gross profit in the three months ended September 30, 2021 was $1.07 billion,
or 64.8% of net sales, compared to $807.9 million, or 61.7% of net sales, in the
three months ended September 30, 2020. Our gross profit in the six months ended
September 30, 2021 was $2.08 billion, or 64.5% of net sales, compared to $1.61
billion, or 61.3% of net sales, in the six months ended September 30, 2020. The
following table summarizes the material and primary drivers of our change in
gross profit as a percentage of net sales, with the material factors discussed
in more detail below the table (dollars in millions):
                               %                                               %
  Gross Profit            of Net Sales            Gross Profit            of Net Sales
                                                                                                Three and six months ended September 30,
$       807.9                        61.7       $     1,606.2                        61.3       2020
                                                                                                Increase in semiconductor net sales at
                                                                                                prior year gross margins and excluding
                                                                                                the impact of other factors quantified in
        204.7                           -               361.7                           -       this table
         12.2                         0.7                26.1                         0.8       Impact of unabsorbed capacity charges
                                                                                                Net impact of product mix and average
         29.8                         1.5                44.6                         1.2       gross profit per unit
                                                                                                Increase in net sales to licensing
                                                                                                customers, which has no associated cost
          9.5                         0.6                15.0                         0.5       of sales
                                                                                                Net impact of excess and obsolete
          4.2                         0.3                22.3                         0.7       inventories

                                                                                                Three and six months ended September 30,
$     1,068.3                        64.8       $     2,075.9                        64.5       2021



Unabsorbed capacity charges - When production levels are below normal capacity,
which we measure as a percentage of the capacity of the installed equipment, we
charge cost of sales for the unabsorbed capacity. We consider normal capacity at
Fab 2 and Fab 4 to be 90% to 95%. We consider normal capacity at Fab 5 to be 70%
to 75%. During the three and six months ended September 30, 2021, we operated at
above normal capacity levels and we expect this to continue if the current
supply constraints relative to demand continue. During the three and six months
ended September 30, 2020, we operated at below normal capacity levels primarily
due to general economic conditions and uncertainty from the COVID-19 pandemic
resulting in unabsorbed capacity charges of $12.2 million and $26.1 million,
respectively. We adjust our wafer fabrication and assembly and test capacity
utilization as required to respond to actual and anticipated business and
industry-related conditions.

Net impact of product mix and average gross profit per unit - The net impact of
product mix and average gross profit per unit may fluctuate over time due to
sales volumes of lower or higher margin products, changes in selling prices, and
fluctuations in product costs. During the three and six months ended September
30, 2021, product mix resulted in a decrease of $29.8 million and $44.6 million,
respectively, in cost of goods sold and an increase in gross profit compared to
the three and six months ended September 30, 2020.

Our overall inventory levels were $713.6 million at September 30, 2021, compared
to $665.0 million at March 31, 2021. We maintained 112 days of inventory on our
balance sheet at September 30, 2021 and March 31, 2021. We expect our days of
inventory levels at December 31, 2021 to be 112 to 118 days.

We anticipate that our gross margins will fluctuate over time, driven primarily
by capacity utilization levels, the overall product mix of microcontroller,
analog, FPGA products, memory products, and technology licensing revenue and the
percentage of net sales of each of these products in a particular quarter, as
well as manufacturing yields, fixed cost absorption, and competitive and
economic conditions in the markets we serve. We continue to transition products
to more advanced process technologies to reduce future manufacturing costs.

We operate assembly and test facilities in Thailand, the Philippines, and other
locations throughout the world. During the three and six months ended September
30, 2021, approximately 59% of our assembly requirements were performed in our
internal assembly facilities, compared to approximately 47% during the three and
six months ended September 30, 2020.  During the three and six months ended
September 30, 2021, approximately 64% of our test requirements were performed in
our internal test facilities, compared to approximately 55% during the three and
six months ended September 30, 2020. The increases in the percentage of assembly
and test operations that were performed internally in the three and six months
ended September 30, 2021 compared to the three and six months ended September
30, 2020 are primarily due to our investments in assembly and test equipment,
which increased our internal capacity capabilities. Third-party contractors
located primarily in
                                       31
--------------------------------------------------------------------------------
  Table of Contents
Asia perform the balance of our assembly and test operations. The percentage of
our assembly and test operations that are performed internally fluctuates over
time based on supply and demand conditions in the semiconductor industry, our
internal capacity capabilities and our acquisition activities. We believe that
the assembly and test operations performed at our internal facilities provide us
with significant cost savings compared to contractor assembly and test costs, as
well as increased control over these portions of the manufacturing process. We
plan to continue to transition certain outsourced assembly and test capacity to
our internal facilities.

We rely on outside wafer foundries for a significant portion of our wafer
fabrication requirements. Approximately 60% and 59% of our net sales came from
products that were produced at outside wafer foundries in the three and six
months ended September 30, 2021, respectively, compared to 61% in each of the
three and six months ended September 30, 2020.

Our use of third parties involves some reduction in our level of control over
the portions of our business that we subcontract. While we review the quality,
delivery and cost performance of our third-party contractors, our future
operating results could suffer if any third-party contractor is unable to
maintain manufacturing yields, assembly and test yields and costs at
approximately their current levels.

Research and Development



R&D expenses for the three months ended September 30, 2021 were $246.2 million,
or 14.9% of net sales, compared to $199.8 million, or 15.3% of net sales, for
the three months ended September 30, 2020. R&D expenses for the six months ended
September 30, 2021 were $484.6 million, or 15.1% of net sales, compared to
$397.8 million, or 15.2% of net sales, for the six months ended September 30,
2020. We are committed to investing in new and enhanced products, including
development systems software, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. R&D costs are expensed as incurred. Assets
purchased to support our ongoing research and development activities are
capitalized when related to products which have achieved technological
feasibility or that have alternative future uses and are amortized over their
expected useful lives. R&D expenses include labor, depreciation, masks,
prototype wafers, and expenses for the development of process technologies, new
packages, and software to support new products and design environments.

R&D expenses increased $46.4 million, or 23.2%, for the three months ended
September 30, 2021 over the same period last year.  R&D expenses increased $86.8
million, or 21.8%, for the six months ended September 30, 2021 over the same
period last year. The primary reason for the increases in R&D costs was higher
compensation costs related to restoring previous reductions in compensation
programs implemented in the six months ended September 30, 2020 due to
uncertainty surrounding the COVID-19 pandemic.

R&D expenses fluctuate over time, primarily due to revenue and operating expense investment levels.

Selling, General and Administrative



Selling, general and administrative expenses for the three months ended
September 30, 2021 were $179.9 million, or 10.9% of net sales, compared to
$144.7 million, or 11.1% of net sales, for the three months ended September 30,
2020. Selling, general and administrative expenses for the six months ended
September 30, 2021 were $354.2 million, or 11.0% of net sales, compared to
$291.0 million, or 11.1% of net sales, for the six months ended September 30,
2020.  Our goal is to continue to be more efficient with our selling, general
and administrative expenses. Selling, general and administrative expenses
include salary expenses related to field sales, marketing and administrative
personnel, advertising and promotional expenditures and legal expenses as well
as costs related to our direct sales force, CEMs and ESEs who work remotely from
sales offices worldwide to stimulate demand by assisting customers in the
selection and use of our products.

Selling, general and administrative expenses increased $35.2 million, or 24.3%,
for the three months ended September 30, 2021 over the same period last year.
Selling, general and administrative expenses increased $63.2 million, or 21.7%,
for the six months ended September 30, 2021 over the same period last year. 

The


primary reason for the increases in selling, general and administrative expenses
was higher compensation costs related to restoring previous reductions in
compensation programs implemented in the six months ended September 30, 2020 due
to uncertainty surrounding the COVID-19 pandemic.

Selling, general and administrative expenses fluctuate over time, primarily due to revenue and operating expense investment levels.


                                       32
--------------------------------------------------------------------------------
  Table of Contents
Amortization of Acquired Intangible Assets

Amortization of acquired intangible assets for the three and six months ended
September 30, 2021 was $215.7 million and $431.3 million, respectively, compared
to $232.9 million and $468.3 million for the three and six months ended
September 30, 2020, respectively. The primary reason for the decreases in
acquired intangible asset amortization was lower amortization from our
acquisition of Microsemi and from our prior acquisitions.

Special Charges and Other, Net



During the three and six months ended September 30, 2021, we incurred special
charges and other, net of $10.2 million and $20.7 million, respectively. During
the three and six months ended September 30, 2020, we incurred special charges
and other, net of $4.3 million and $4.6 million, respectively. The costs
incurred during these periods were primarily related to restructuring of
acquired and existing wafer fabrication operations to increase operational
efficiency, and individually insignificant one-time costs associated with
litigation matters and exiting non-manufacturing facilities including contract
termination costs, employee severance, and the disposal of assets.

Other Income (Expense)

Interest income in the three and six months ended September 30, 2021 was $0.1 million and $0.4 million, respectively, compared to $0.3 million and $0.6 million, respectively, for the three and six months ended September 30, 2020.



Interest expense in the three and six months ended September 30, 2021 was $64.8
million and $137.1 million, respectively, compared to $93.3 million and $192.4
million, respectively, for the three and six months ended September 30, 2020.
The primary reason for the decreases in interest expense relates to the
cumulative pay down of our debt and lower interest rates on our outstanding
variable rate debt.

During the three and six months ended September 30, 2021, we recognized losses
of $85.2 million and $85.5 million, respectively, related to the settlement of a
portion of our outstanding 2015 Senior Convertible Debt, our 2017 Senior
Convertible Debt, and our 2017 Junior Convertible Debt as well as the repayment
of $1.00 billion aggregate principal amount outstanding of our 3.922% 2021
Notes. The net losses recognized on the settlement of our Convertible Debt are
comprised of two components (i) the inducement loss, which is the excess of the
fair value of the consideration provided to the holder over the fair value of
the debt and (ii) the extinguishment loss or gain, which is the difference
between the fair value of the debt component and the carrying value on the
settlement date. During the three and six months ended September 30, 2020, we
recognized losses of $45.1 million and $71.9 million, respectively, related to
the settlement of a portion of our outstanding 2015 Senior Convertible Debt, our
2017 Senior Convertible Debt, and our 2017 Junior Convertible Debt as well as
the payment of all amounts outstanding under our Bridge Loan Facility.

Other loss, net in the three months ended September 30, 2021 was $1.6 million
compared to other income, net of $0.7 million for the three months ended
September 30, 2020. Other loss, net in the six months ended September 30, 2021
was $1.1 million compared to other loss, net of $2.5 million for the six months
ended September 30, 2020. The primary reason for these changes relates to
foreign currency exchange rate fluctuations.

Provision for Income Taxes



Our provision or benefit for income taxes is attributable to U.S. federal,
state, and foreign income taxes. A comparison of our effective tax rates in the
six months ended September 30, 2021 and September 30, 2020 is not meaningful due
to the amount of pre-tax income, and income tax benefits recorded during the
prior period.

We are subject to taxation in many jurisdictions in which we have operations.
The effective tax rates that we pay in these jurisdictions vary widely, but they
are generally lower than our combined U.S. federal and state effective tax rate.
Our domestic blended statutory tax rate in each of the six months ended
September 30, 2021 and September 30, 2020 was approximately 22%. Our non-U.S.
blended statutory tax rates in the six months ended September 30, 2021 and
September 30, 2020 were much lower than this amount. The difference in rates
applicable in foreign jurisdictions results from a number of factors, including
lower statutory rates, tax holidays, financing arrangements and other factors.
Our effective tax rate has been and will continue to be impacted by the
geographical dispersion of our earnings and losses.

Our foreign tax rate differential benefit primarily relates to our operations
and assets in Thailand, Malta and Ireland. Our Thailand manufacturing operations
are currently subject to numerous tax holidays granted to us based on our
investment in property, plant and equipment in Thailand. Our tax holiday periods
in Thailand expire at various times in the future; however,
                                       33
--------------------------------------------------------------------------------
  Table of Contents
we actively seek to obtain new tax holidays, otherwise we will be subject to tax
at the statutory tax rate of 20%. We do not expect the future expiration of any
of our tax holiday periods in Thailand to have a material impact on our
effective tax rate.  The remaining material components of foreign income taxed
at a rate lower than the U.S. are earnings accrued in Ireland at a 12.5%
statutory tax rate and earnings accrued in Malta at a 0% to 5% tax rate.

In September 2021, we received a Statutory Notice of Deficiency (Notice) from
the Internal Revenue Service (IRS) for fiscal 2007 through fiscal 2012. The
disputed amounts largely relate to transfer pricing matters. We firmly believe
that the assessments are without merit and plan to pursue all available
administrative and judicial remedies necessary to resolve this matter.
Initially, we expect to file a petition in the United States Tax Court
challenging the Notice. We intend to vigorously defend our position and we are
confident in our ability to prevail on the merits. We regularly assess the
likelihood of adverse outcomes resulting from examinations such as this to
determine the adequacy of our tax reserves. We believe that the final
adjudication of this matter will not have a material impact on our consolidated
financial position, results of operations or cash flows and that we have
adequate tax reserves for all tax matters. However, the ultimate outcome of
disputes of this nature is uncertain, and if the IRS were to prevail on all of
its assertions, the assessed tax, penalties, and deficiency interest could have
a material adverse impact on our financial position, results of operations or
cash flows.

Various taxing authorities in the U.S. and other countries in which we do
business are increasing their scrutiny of the tax structures employed by
businesses. Companies of our size and complexity are regularly audited by the
taxing authorities in the jurisdictions in which they conduct significant
operations. For U.S. federal, and in general for U.S. state tax returns, our
fiscal 2007 and later tax returns remain effectively open for examination by the
taxing authorities. We are currently being audited by the tax authorities in the
U.S. and in various foreign jurisdictions. At this time, we do not know what the
outcome of these audits will be. We record benefits for uncertain tax positions
based on an assessment of whether it is more likely than not that the tax
positions will be sustained based on their technical merits under currently
enacted law. If this threshold is not met, no tax benefit of the uncertain tax
position is recognized. If the threshold is met, we recognize the largest amount
of the tax benefit that is more than 50% likely to be realized upon ultimate
settlement.


                                       34

--------------------------------------------------------------------------------
  Table of Contents
Liquidity and Capital Resources

We had $255.3 million in cash, cash equivalents and short-term investments at September 30, 2021, a decrease of $26.7 million from the March 31, 2021 balance.



Net cash provided by operating activities was $1.24 billion in the six months
ended September 30, 2021 compared to $957.6 million in the six months ended
September 30, 2020. The increase in net cash provided by operating activities
was primarily due to higher net sales compared to the prior year period, which
was unfavorably impacted by uncertainty surrounding the COVID-19 pandemic,
offset by efforts focused on working capital and discretionary spending
management.

Net cash used in investing activities was $208.7 million in the six months ended
September 30, 2021 compared to $58.6 million in the six months ended September
30, 2020. During the six months ended September 30, 2021 and September 30, 2020,
net investing activities primarily related to capital purchases and investments
in other assets.

Our level of capital expenditures varies from time to time as a result of actual
and anticipated business conditions. Capital expenditures in the six months
ended September 30, 2021 were $164.8 million compared to $15.8 million in the
six months ended September 30, 2020. Capital expenditures were primarily for the
expansion of production capacity and the addition of research and development
equipment. Towards the second half of fiscal 2021 we started to invest more
significantly to expand manufacturing capacity in response to supply constraints
relative to current demand levels and we expect this to continue through
calendar 2022. We currently expect to invest between $350.0 million and $450.0
million in equipment and facilities during the next twelve months. We believe
that the capital expenditures anticipated to be incurred over the next twelve
months will provide sufficient manufacturing capacity to support the growth of
our production capabilities for our new products and technologies and to bring
in-house more of the assembly and test operations that are currently outsourced.
We expect to finance our capital expenditures through our existing cash balances
and cash flows from operations.

Net cash used in financing activities was $1.06 billion in the six months ended
September 30, 2021 compared to $931.7 million in the six months ended September
30, 2020. Significant transactions affecting our net financing cash flows
include:
•in the first six months of fiscal 2022, $806.6 million of cash used to pay down
certain principal of our debt, including the cash portion of the settlement of
our 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt and our 2017
Junior Convertible Debt, our Revolving Credit Facility and our 3.922% 2021
Notes, partially funded by the issuance of our senior notes, and
•in the first six months of fiscal 2021, $743.0 million of cash used to pay down
certain principal of our debt, including the cash portion of the settlement of
our 2015 Senior Convertible Debt and our 2017 Senior Convertible Debt, partially
funded by the issuance of our senior notes, and
•in the first six months of fiscal 2022 and fiscal 2021, we paid cash dividends
to our stockholders of $234.3 million and $185.7 million, respectively.

In March 2020 and September 2019, we amended our Credit Agreement dated May 29,
2018, to, among other things, reduce the margin added to the interest rate on
revolving loans under the Credit Agreement and amend certain negative covenants,
including covenants that restrict our and our subsidiaries' ability to, among
other things, incur subsidiary indebtedness, grant liens and enter into certain
restrictive agreements. The amendments also allow us the option to factor
receivables and certain related assets. The amendments lowered the Revolving
Credit Facility thereunder to $3.57 billion from $3.60 billion. The revolving
loan commitments terminate in May 2023 and bear interest, at our option, at the
base rate plus a spread of 0.00% to 0.75% or an adjusted LIBOR rate plus a
spread of 1.00% to 1.75%, in each case, with such spread being determined based
on the consolidated senior leverage ratio for the preceding four fiscal quarter
period.

As of September 30, 2021, the principal amount of our outstanding indebtedness
was $8.41 billion. At September 30, 2021, we had $1.81 billion of outstanding
borrowings under the Revolving Credit Facility compared to $2.35 billion
at March 31, 2021. During fiscal 2021, we used borrowings under our Revolving
Credit Facility and proceeds from the issuance of our 0.972% 2024 Notes to repay
all amounts outstanding under our Term Loan Facility. See Note 6 of the notes to
our condensed consolidated financial statements for more information regarding
our contractual obligations related to our long-term debt.

The enactment of the TCJA imposed a tax on all previously untaxed earnings of
non-U.S. subsidiaries of U.S. corporations. Due to this change, the jurisdiction
in which our cash is at any given point in time no longer has a significant
impact on our liquidity.  Future distributions of a significant portion of our
non-U.S. assets to the U.S. will no longer be subject to U.S. federal taxation.
We intend to invest substantially all of our foreign subsidiary earnings, as
well as our capital in our foreign subsidiaries, indefinitely outside of the
U.S. in those jurisdictions in which we would incur significant, additional
costs upon repatriation of such amounts. During fiscal 2018, we recognized a
one-time transition tax on accumulated unrepatriated foreign
                                       35

--------------------------------------------------------------------------------


  Table of Contents
earnings, of which we expected cash payments of approximately $290.3 million.
This tax is payable over a period of eight years, with 8% of the transition tax
payable each year for fiscal 2019 through fiscal 2023, and 15%, 20%, and 25%,
respectively, payable during fiscal 2024, fiscal 2025, and fiscal 2026. As of
September 30, 2021, our transition tax payable was $197.4 million, of which
$23.2 million is payable within the next 12 months.

We enter into derivative transactions from time to time in an attempt to reduce
our exposure to currency rate fluctuations. Although none of the countries in
which we conduct significant foreign operations has had a highly inflationary
economy in the last five years, there is no assurance that inflation rates or
fluctuations in foreign currency rates in countries where we conduct operations
will not adversely affect our operating results in the future. At September 30,
2021, we had no foreign currency forward contracts outstanding.

We did not repurchase any shares of our common stock in the first six months of
fiscal 2022 and fiscal 2021. As of September 30, 2021, we held approximately
19.6 million shares as treasury shares.

On October 28, 2002, we announced that our Board of Directors had approved and
instituted a quarterly cash dividend on our common stock. A quarterly cash
dividend of $0.2185 per share was paid on September 3, 2021 in the aggregate
amount of $121.2 million. A quarterly dividend of $0.232 per share was declared
on November 2, 2021 and will be paid on December 3, 2021 to stockholders of
record as of November 19, 2021. We expect the aggregate cash dividend for the
December 2021 quarter to be approximately $129.0 million. Our Board is free to
change our dividend practices at any time and to increase or decrease the
dividend paid, or not to pay a dividend on our common stock on the basis of our
results of operations, financial condition, cash requirements and future
prospects, and other factors deemed relevant by our Board. Our current intent is
to provide for ongoing quarterly cash dividends depending upon market
conditions, our results of operations, and potential changes in tax laws.

We believe that our existing sources of liquidity combined with cash generated
from operations and borrowings under our Revolving Credit Facility will be
sufficient to meet our currently anticipated cash requirements for at least the
next 12 months. However, the semiconductor industry is capital intensive. In
order to remain competitive, we must constantly evaluate the need to make
significant investments in capital equipment for both production and research
and development. We may increase our borrowings under our Revolving Credit
Facility or seek additional equity or debt financing from time to time to
maintain or expand our wafer fabrication and product assembly and test
facilities, for cash dividends, for share repurchases or for acquisitions or
other purposes. The timing and amount of any such financing requirements will
depend on a number of factors, including our level of dividend payments, changes
in tax laws and regulations regarding the repatriation of offshore cash, demand
for our products, changes in industry conditions, product mix, competitive
factors and our ability to identify suitable acquisition candidates. We may from
time to time seek to refinance certain of our outstanding notes or Convertible
Debt through issuances of new notes or convertible debt, tender offers, exchange
transactions or open market repurchases. Such issuances, tender offers or
exchanges or purchases, if any, will depend on prevailing market conditions, our
ability to negotiate acceptable terms, our liquidity position and other factors.
There can be no assurance that any financing will be available on acceptable
terms due to uncertainties resulting from the COVID-19 pandemic or other
factors, and any additional equity financing would result in incremental
ownership dilution to our existing stockholders.

© Edgar Online, source Glimpses